Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02905513
Other study ID # 10998
Secondary ID
Status Completed
Phase N/A
First received September 14, 2016
Last updated February 6, 2018
Start date November 16, 2016
Est. completion date November 30, 2017

Study information

Verified date September 2017
Source London School of Hygiene and Tropical Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone app instant messaging on the acceptability of effective contraception in Tajikistan. Woman and men aged 16-24 will be randomised to have access to the Tajik Family Planning Alliance's sexual and reproductive health app (control) or the app plus 0-3 instant messages a day for 4 months (intervention). Participants will complete a questionnaire at baseline and 4 months.


Recruitment information / eligibility

Status Completed
Enrollment 580
Est. completion date November 30, 2017
Est. primary completion date July 31, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years to 24 Years
Eligibility Inclusion Criteria:

- Aged 16-24

- Own a personal Android mobile phone

- Live in Tajikistan

Exclusion Criteria:

- Cannot read Tajik or Russian

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Contraceptive app instant messages

Other:
Mobile phone app


Locations

Country Name City State
Tajikistan Tajik Family Planning Alliance Dushanbe

Sponsors (3)

Lead Sponsor Collaborator
London School of Hygiene and Tropical Medicine International Planned Parenthood Federation, Tajik Family Planning Alliance

Country where clinical trial is conducted

Tajikistan, 

Outcome

Type Measure Description Time frame Safety issue
Other Knowledge of effective contraception Score on the knowledge measure 4 months
Other Perceived norms in relation to using and communicating with partners about contraception Responses to the perceived norms scales 4 months
Other Personal agency in using (women only) and communicating with partners about contraception Responses to the personal agency scales 4 months
Other Intention to use effective contraception (women only) Score on the intention measure 4 months
Other Intervention 'dose' received If participants read all, some, most or none of the messages and if they stopped the messages 4 months
Primary Acceptability of at least one method of effective contraception The proportion reporting that at least one method of effective contraception is acceptable (pill, intrauterine device, injection, implant) 4 months
Secondary Use of effective contraception The proportion reporting current use of effective contraception (pill, intrauterine device, injection, implant) 4 months
Secondary Acceptability of individual effective contraceptive methods The proportion reporting that individual methods of effective contraception are acceptable (pill, intrauterine device, injection, implant) 4 months
Secondary Discontinuation of effective contraception The proportion reporting use (or partner's use) of effective contraception at any time during the 4 months (pill, intrauterine device, injection, implant, patch) 4 months
Secondary Service uptake The proportion reporting attending a sexual health service during the 4 months 4 months
Secondary Unintended pregnancy The proportion reporting that they became pregnant (or partner became pregnant) and did not want to become pregnant during the study 4 months
Secondary Induced abortion The proportion reporting having (or partner having) an abortion during the study 4 months
See also
  Status Clinical Trial Phase
Completed NCT02577601 - Impact of Combined Hormonal Contraceptives on UPA Phase 4
Completed NCT03153644 - Improving Contraceptive Care for Women With Medical Conditions
Completed NCT04112095 - Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Phase 3
Recruiting NCT05521646 - Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative N/A
Active, not recruiting NCT04291001 - Ovarian Function With ENG Implant and UPA Use Early Phase 1
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Completed NCT03438682 - Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
Active, not recruiting NCT01948882 - Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women N/A
Enrolling by invitation NCT04997499 - Adolescent Subcutaneous (SQ) Injection Video Validation N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2
Completed NCT04463680 - Rifampin and the Contraceptive Implant Phase 4
Completed NCT03154125 - Sayana® Press Extension Study Phase 3
Withdrawn NCT03725358 - A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon. N/A
Completed NCT02957630 - "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" Phase 1/Phase 2
Completed NCT02718222 - Impact and Performance of Institutionalizing Immediate Post-partum IUD Services N/A
Completed NCT02456584 - Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods Phase 1
Recruiting NCT02121067 - LNG-IUS at 2 Weeks Postpartum Phase 4
Terminated NCT02169869 - Immediate Postplacental IUD Insertion N/A
Recruiting NCT02292056 - Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions N/A
Withdrawn NCT01930994 - Kenya Sino-implant (II) PK Study N/A